Free Trial

Mustang Bio (MBIO) Stock Forecast & Price Target

Mustang Bio logo
$0.27
-0.01 (-3.61%)
(As of 11/1/2024 ET)

Mustang Bio - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for Mustang Bio in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for MBIO.

Consensus Price Target

$2.00
648.78% Upside
According to the 1 analysts' twelve-month price targets for Mustang Bio, the average price target is $2.00. The highest price target for MBIO is $2.00, while the lowest price target for MBIO is $2.00. The average price target represents a forecasted upside of 648.78% from the current price of $0.27.
Get the Latest News and Ratings for MBIO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Mustang Bio and its competitors.

Sign Up

MBIO Analyst Ratings Over Time

TypeCurrent Forecast
11/3/23 to 11/2/24
1 Month Ago
10/4/23 to 10/3/24
3 Months Ago
8/5/23 to 8/4/24
1 Year Ago
11/3/22 to 11/3/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.00$2.00$12.00$25.80
Forecasted Upside648.78% Upside798.88% Upside3,763.49% Upside1,391.33% Upside
Consensus Rating
Buy
Buy
Buy
Buy

MBIO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MBIO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Mustang Bio Stock vs. The Competition

TypeMustang BioMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.79
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside648.78% Upside15,872.29% Upside10.56% Upside
News Sentiment Rating
Positive News

See Recent MBIO News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/13/2024HC Wainwright
2 of 5 stars
 Lower TargetBuy ➝ Buy$25.00 ➝ $2.00+692.05%
8/24/2023Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$18.00+516.44%
8/15/2023BTIG Research
2 of 5 stars
 Lower TargetBuy ➝ Buy$20.00 ➝ $16.00+296.04%
5/26/2023B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Mamtani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Target$4.00 ➝ $10.00+99.20%
11/17/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$60.00+669.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:16 AM ET.


MBIO Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Mustang Bio is $2.00, with a high forecast of $2.00 and a low forecast of $2.00.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mustang Bio in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBIO shares.

According to analysts, Mustang Bio's stock has a predicted upside of 648.78% based on their 12-month stock forecasts.

Analysts like Mustang Bio more than other "medical" companies. The consensus rating for Mustang Bio is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MBIO compares to other companies.


This page (NASDAQ:MBIO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners